Skip to content

Studies on the specificity of neurochemical and behavioral effects of LSD-25.

S B Sparber, L P Dwoskin, M S Kleven

Pharmacology, Biochemistry, and Behavior February 1986 DOI: 10.1016/0091-3057(86)90363-1 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Preclinical animal experiment Peer reviewed
Population Conscious rats engaged in operant behavior
Interventions Fluoxetine LSD 5-HTP methysergide mianserin
Topics LSD
Key findings The authors argue there is probably more than one functional pool of CNS serotonin, with the LSD-sensitive pool newly synthesized and representing only a small fraction of total serotonin. Methysergide blocked LSD-induced pausing but not the decreased responding rate, whereas mianserin blocked both. They propose low-dose LSD effects reflect sympathetic arousal and may model agitated depression or anxiety.

Abstract

Brain perfusion experiments of conscious rats engaged in operant behavior and administered fluoxetine or LSD, with or without prior injection of 5-HTP, indicate there is probably more than one functional pool of 5-HT in the CNS. Furthermore, the fact that prior loading with the precursor is necessary before unmasking an effect of LSD suggests the LSD-sensitive pool is newly synthesized and represents only a small fraction of total CNS serotonin. Separating the effects of LSD's behavioral action into pausing (disruption) and depressed responding rate, with or without pausing, enabled us to demonstrate blockade of the disruption by methysergide without blockade of the decreased responding rate. Mianserin blocks both effects of LSD's action. We suggest that behavioral effects of low doses of LSD are due to sympathetic arousal and may offer a model for agitated depression and/or anxiety and that drugs of the mianserin-type may prove useful for treating some forms of anxiety, as well as depression.

Comparable studies

Other preclinical and animal studies on LSD, most cited first.

Study Year Design Participants
Transcriptome Fingerprints Distinguish Hallucinogenic and Nonhallucinogenic 5-Hydroxytryptamine 2A Receptor Agonist Effects in Mouse Somatosensory Cortex Human embryonic kidney 293 cells stably expressing 5-HT2ARs; wild-type and 5-HT2AR... 2003 Experimental study
Evidence for a central 5‐hydroxytryptamine receptor stimulation by lysergic acid diethylamide Rats 1968 Experimental study
Psychedelics, but Not Ketamine, Produce Persistent Antidepressant-like Effects in a Rodent Experimental System for the Study of Depression Rats 2020 Preclinical study
Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission Male mice 2021 Multidisciplinary experimental study with in vivo electrophysiology, optogenetics, behavioral paradigms, molecular biology, and conditional knockout mice
A non-hallucinogenic LSD analog with therapeutic potential for mood disorders. Mice and cultured rat cortical neurons 2023 Preclinical study

Citations in the library

Explore topics